Atlas Trials

A Study of JR-171 in Patients With Mucopolysaccharidosis I

Clinical trial NCT04227600 · COMPLETED

Trial details

NCT number
NCT04227600
Sponsor
JCR Pharmaceuticals Co., Ltd.
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Mucopolysaccharidosis I
Start date
2020-09-01
Primary completion
2022-08-02
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.